Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
Earnings Data
Report Date
Apr 30, 2026Before Open (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
1.39Last Year’s EPS
1.32Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call balanced clear operational and financial strengths — notably strong free cash flow (+~13% YTD), margin expansion (first nine months gross margin +50 bps and Q4 guide to ~57%), strategic acquisition (Pillar Five) to remedy long-standing Clear Eyes supply issues, and opportunistic buybacks — against persistent near-term headwinds driven by Clear Eyes supply constraints, category softness in analgesics/cough & cold/lice, a $10M supplier loan write-off, and volatile retailer ordering patterns. Management projects continued sequential supply improvements and maintained full-year free cash flow and narrowed EPS and revenue guidance, indicating confidence in financial resilience while acknowledging ongoing execution and demand uncertainties.Company Guidance
Solid Q3 Revenue and Slight Beat to Forecast
Q3 sales of $283.4 million (down 2.4% vs. prior year, or down 2.2% excluding FX) were slightly ahead of company expectations, demonstrating resilience amid a volatile consumer backdrop.
Strong Free Cash Flow and Capital Allocation
Year-to-date free cash flow of $208.8 million, up ~13% versus prior year. Maintaining full-year free cash flow guidance of $245 million or more. Strong cash generation enabled the acquisition of Pillar Five (~$110M) and opportunistic share repurchases (~$46M in Q3; over $150M year-to-date, ~5% of shares outstanding).
Margin Strength and Earnings Outlook
Q3 gross margin approximately 55.5% (first nine months 55.7%, up 50 bps year-over-year). Company expects a ~57% adjusted gross margin in Q4. Adjusted diluted EPS was $1.14 for Q3 (vs. $1.22 prior year) with full-year adjusted diluted EPS narrowed to ~ $4.54 and FY-to-date EPS of $3.16 (vs. $3.20 prior year).
Strategic Acquisition to Improve Supply Chain (Pillar Five)
Closed Pillar Five acquisition in December (just over $110M) and installed a new high-speed production line; management expects Pillar Five to support the majority of future eye care production internally over time, helping to accelerate Clear Eyes supply improvements.
Sequential Improvement in Clear Eyes Supply
Clear Eyes supply showed sequential improvement for the second quarter in a row in Q3, with management expecting continued sequential improvement in Q4 (targeting three consecutive quarters of improvement) and additional ramping through calendar 2026.
Channel and Brand Strengths
E-commerce/consumption grew over 10% in Q3 and helped offset weaker channels. Strong performances highlighted in GI (Fleet, Dramamine), Skin (Compound W expansion into SkinTag), and Women’s Health (Monistat at historic peak share).
Healthy Balance Sheet and Leverage Position
Net debt ~ $1.0 billion with covenant-defined leverage ratio of 2.6x (mid-2s). Company retains optionality for M&A, brand investment, continued buybacks, and deleveraging.
PBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 05, 2026 | $67.03 | $65.55 | -2.21% |
Nov 06, 2025 | $59.83 | $61.36 | +2.56% |
Aug 07, 2025 | $75.16 | $67.61 | -10.05% |
May 08, 2025 | $81.41 | $87.04 | +6.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare (PBH) is schdueled to report earning on Apr 30, 2026, Before Open (Confirmed).
What is Prestige Consumer Healthcare (PBH) earnings time?
Prestige Consumer Healthcare (PBH) earnings time is at Apr 30, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBH EPS forecast?
PBH EPS forecast for the fiscal quarter 2026 (Q4) is 1.39.